Gyeonggi-do, South Korea

Hae Hum Jung


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hae Hum Jung: Innovator in CETP Inhibition

Introduction: Hae Hum Jung is an accomplished inventor based in Gyeonggi-do, South Korea. With a focus on pharmaceutical innovations, he has made significant contributions to the field of cholesterol management. His work primarily revolves around a novel approach to inhibiting CETP (Cholesteryl Ester Transfer Protein), a critical component in regulating lipid levels in the body.

Latest Patents: Hae Hum Jung holds one notable patent titled "Oxazolidinone derivative as CETP inhibitor, its preparation method, and pharmaceutical composition comprising the same." This patent presents a new oxazolidinone derivative that exhibits remarkable inhibitory activity against CETP. The innovative preparation method and the accompanying pharmaceutical composition can be instrumental in preventing or treating diseases related to CETP enzyme activity and HDL cholesterol levels, such as dyslipidemia, atherosclerosis, and coronary heart disease.

Career Highlights: Hae Hum Jung is currently associated with Dong-a ST Co., Ltd., a reputable company in the pharmaceutical sector. His role as an inventor at the company highlights his dedication to advancing healthcare solutions. Jung's expertise in pharmaceutical chemistry and his innovative mindset contribute significantly to the company’s research and development endeavors.

Collaborations: Throughout his career, Hae Hum Jung has collaborated with competent professionals, including his coworkers Jang Hyun Park and Seung Hyun Song. These collaborations have enriched the research environment and fostered a culture of innovation, resulting in valuable contributions to the field.

Conclusion: Hae Hum Jung's commitment to enhancing therapeutic options for lipid-related disorders is evident through his patent and ongoing work. As an inventor, his contributions to CETP inhibition not only showcase his scientific prowess but also hold the potential to improve the quality of life for individuals affected by related health issues. His journey as an inventor exemplifies the vital role of innovation in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…